What is the percentage of Subacute Sclerosing Panencephalitis (SSPE) cases resulting from measles infection at 5 years or older?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SSPE Risk by Age at Measles Infection

The risk of SSPE following measles infection at age 5 years or older is approximately 1 in 100,000 measles cases, which is 16 times lower than the risk when measles occurs before age 1 year. 1

Age-Stratified SSPE Risk Data

The evidence clearly demonstrates that age at measles infection is the most critical determinant of SSPE risk, with a dramatic inverse relationship between age and subsequent SSPE development:

Specific Risk by Age Group

  • Under 1 year of age: 18 per 100,000 measles cases (highest risk) 2
  • Under 2 years of age: Nearly half of all SSPE cases had measles before age 2 1
  • Under 5 years of age: 6.5-11 per 100,000 measles cases 3; California data shows 1 in 1,367 cases 4
  • Age 5 years or older: Approximately 1 per 100,000 measles cases (16-fold lower risk than infection under age 1) 1

Overall Population Risk

The baseline SSPE risk across all ages is 4-11 per 100,000 measles cases 5, 6, 3, but this aggregate figure masks the profound age-dependent variation. Children who contract measles at age 5 or older represent the lowest-risk group for SSPE development. 1

Critical Clinical Context

Why Age Matters

  • 71% of SSPE cases had documented measles-like illness before 15 months of age 4
  • The median latency period between measles infection and SSPE onset is 8-9.5 years 1, 4
  • Male predominance exists (2.4-2.8:1 ratio) across all age groups 1, 4

Underreporting Caveat

These risk estimates are based on reported measles cases, which represent only approximately 11% of actual infections. 6 The true denominator of measles cases is much larger, meaning the actual per-infection SSPE risk may be lower than these figures suggest, though the age-dependent pattern remains consistent.

Prevention Implications

Measles vaccination has essentially eliminated SSPE in highly vaccinated populations and remains the only effective prevention strategy. 7, 5, 6 The vaccine carries an SSPE risk of only 0.14 per 100,000 doses—dramatically lower than natural infection at any age—and does not increase SSPE risk even in previously infected individuals. 7, 2

References

Research

Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

Guideline

Genetic Predispositions and Prevention Strategies for Subacute Sclerosing Panencephalitis (SSPE)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Risk of SSPE When Accounting for Measles Underreporting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.